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Abstract
Influenza virus tissue tropism defines the host cells and tissues that support viral replication and contributes to determining
which regions of the respiratory tract are infected in humans. The location of influenza virus infection along the respiratory
tract is a key determinant of virus pathogenicity and transmissibility, which are at the basis of influenza burdens in the
human population. As the pathogenicity and transmissibility of influenza virus ultimately determine its reproductive fitness
at the population level, strong selective pressures will shape influenza virus tissue tropisms that maximize fitness. At
present, the relationships between influenza virus tissue tropism within hosts and reproductive fitness at the population
level are poorly understood. The selective pressures and constraints that shape tissue tropism and thereby influence the
location of influenza virus infection along the respiratory tract are not well characterized. We use mathematical models that
link within-host infection dynamics in a spatially-structured human respiratory tract to between-host transmission dynamics,
with the aim of characterizing the possible selective pressures on influenza virus tissue tropism. The results indicate that
spatial heterogeneities in virus clearance, virus pathogenicity or both, resulting from the unique structure of the respiratory
tract, may drive optimal receptor binding affinity–that maximizes influenza virus reproductive fitness at the population
level–towards sialic acids with a2,6 linkage to galactose. The expanding cell pool deeper down the respiratory tract, in
association with lower clearance rates, may result in optimal infectivity rates–that likewise maximize influenza virus
reproductive fitness at the population level–to exhibit a decreasing trend towards deeper regions of the respiratory tract.
Lastly, pre-existing immunity may drive influenza virus tissue tropism towards upper regions of the respiratory tract. The
proposed framework provides a new template for the cross-scale study of influenza virus evolutionary and epidemiological
dynamics in humans.
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Introduction
Seasonal influenza A annually causes up to a billion cases
and up to half-a-million deaths worldwide, leading to consid-
erable economic losses [1]. Influenza burdens can be increased
greatly during pandemics, which are triggered by the intro-
duction of novel influenza A viruses, typically from animal
reservoirs, into the human population. Although rare events,
past pandemics have each resulted in up to 50 million deaths
worldwide [2].
Influenza burdens are a result of disease severity in individual
hosts and the size of epidemic or pandemic waves at the
population level. Influenza virus tissue tropism defines host cells
and tissues that support viral replication, and governs at least
partly which regions of the respiratory tract are infected in
humans. The location of infection along the human respiratory
tract is an essential determinant of virus pathogenicity and
transmissibility [3–5], which are at the basis of influenza burdens.
Pathogenicity typically increases as infection is located deeper
down the respiratory tract because of the delicate nature and vital
function of deeper airways and alveoli [3]. Conversely, transmis-
sibility appears favoured with infection located higher up [4–9].
Avian influenza viruses that predominantly infect deeper regions
of the respiratory tract (DRRT, i.e., bronchioles and alveoli) do
not efficiently transmit among humans. Furthermore, genetic
mutations in influenza virus genome that result in reduced tropism
for upper regions of the respiratory tract (URRT, i.e., nose,
trachea and bronchi) impair or abolish virus transmissibility in
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animal models [9–12], while genetic mutations that enhance
URRT tropism can restore transmissibility [10,12,13].
Pathogenicity and transmissibility primarily determine influenza
virus population-level fitness, usually measured by the basic
reproductive number, R0, and defined by the number of
secondary cases arising from one infected individual in a
susceptible population. Mathematically, R0 is defined by the
product of transmission rate and infectious period, both of which
are dependent on pathogenicity and transmissibility (i.e., the
intrinsic ability of the virus to be transmitted from one individual
to another) [14]. Consequently, tissue tropism–which contributes
to determining pathogenicity and transmissibility–will be under
strong selective pressure to maximize fitness. In other words, there
may be an optimal location for influenza virus infection along the
respiratory tract that maximizes R0 [15]. However, the relation-
ships between influenza virus tissue tropism in individual hosts and
reproductive fitness at the population level are currently poorly
understood, hence the selective pressures on influenza virus tissue
tropism are not well characterized.
In this paper, we use cross-scale mathematical models of
infection dynamics linking influenza virus within-host dynamics in
a spatially-structured respiratory tract to population-level dynam-
ics of transmission in a homogeneous and well-mixed population,
to unveil the possible selective pressures on influenza virus tissue
tropism. The proposed framework builds on recent developments
in the cross-scale modeling of virus infection dynamics, whereby
parameters of between-host models are estimated based on the
dynamics of infection in individual hosts, as captured by within-
host models [15–17]. These cross-scale or nested models have shed
light on the evolutionary dynamics of immune escape and
virulence by linking within-host and population-level scales;
dynamics that could not be revealed by models addressing either
of these scales separately. We propose to use a similar approach to
explore the evolutionary dynamics of influenza virus tissue
tropism. Because tissue tropism specifically refers to spatially-
explicit dynamics within individual hosts, we introduce spatially-
structured within-host models into the framework. Spatially-
structured within-host models have proved useful tools for the
study of within-host infection dynamics of human immunodefi-
cient virus and hepatitis C virus in the presence of target cell
heterogeneities [18,19]. They shed light on the mechanisms
behind multiple phases of infection or different courses of disease
progression. Here we show that spatially-structured within-host
models nested into between-host models of infection dynamics can
provide insights into possible selective pressures shaping influenza
virus tissue tropism, and highlight the reciprocal relationships
between influenza virus tissue tropism within hosts and reproduc-
tive fitness at the population level.
Materials and Methods
Conceptual Overview
Within-host models of infection dynamics in a spatially-
structured respiratory tract composed of linearly-connected
respiratory compartments were developed. These allowed to
quantitatively assess overall viral excretion (X) and pathogenicity
(P) of viruses with different cellular tropisms. The quantitative
measures of viral excretion (X) and pathogenicity (P) were then
used to estimate the population-level reproductive number (R) of
the viruses when circulating in a homogeneous and well-mixed
human population (Fig. 1). Optimal tissue tropisms were defined
as the cellular tropisms that maximized the virus reproductive
number.
Mathematical Model of Within-host Infection Dynamics
We developed a set of coupled differential equation models to
capture the dynamics of influenza virus infection and host immune
responses in the respiratory tract of individual hosts. Host adaptive
immune responses were modeled in order to allow re-infection of
hosts with pre-existing immunity. The minimal general format of
the models was based on previously published work [16,17,20–22],
modified as follows:
Susceptible cells
dS=dt~{bSV{cSF
Infected cells
dI=dt~bSV{aI{etIT
Cells refractory to infection
dR=dt~cSF
Free infective virus
dV=dt~vpI{mvV{eaAV{egGV{xV
Type I interferon
dF=dt~prf I{mf F
Cytotoxic T cells
dT=dt~prtIDtt{mtT{etIT
IgA
dA=dt~praVDta{maA{eaAV
IgG
dG=dt~prgVDtg{mgG{egGV ð1Þ
Susceptible cells (S) become infected with virus (V) at an
infectivity rate (b) or become refractory to infection due to the
action of type I interferon (F) at a rate c. A refractory state to
infection, triggered by host innate immune responses (type I
interferon), was included to avoid cell depletion [20]. Infected cells
(I) are killed by the infection at a rate a and by cytotoxic T cells (T)
at a rate et. They produce virus (V) at a rate vp. Virus (V) decays at
a rate mv, and is neutralized by immunoglobulins of type A (IgA; A)
at a rate ea and by immunoglobulins of type G (IgG; G) at a rate
eg, or is cleared by the muco-ciliary escalator at a rate x. Type I
interferon (F) is produced proportionally to the number of infected
cells (I) at a rate prf and decays at a rate mf. Cytotoxic T cells (T)
proliferate proportionally to the number of infected cells (I) at a
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rate prt, with a delay of Dtt, and die at a rate mt. IgA (A) and IgG
(G) are produced proportionally to the number of free virus (V) at
a rate pra and prg, with a delay of Dta and Dtg, and decay at a rate
ma and mg, respectively. IgA and IgG levels one year following
primary infection are used as pre-existing immunity levels to
model re-infection dynamics.
More complex versions of the models included the following
variations. Birth and natural death processes of respiratory
epithelial cells were added. The birth rate of respiratory epithelial
cells was set based on the initial appearance of epithelial
hyperplasia following infection, which typically appears along
the respiratory tract around 3 days post-infection, irrespective of
the region involved [3,23]. The death rates of respiratory epithelial
cells along the airways and of pneumocytes in the alveoli were set
based on their respective lifespan of 6 and 18 months [24]. The
immune system was further modeled with variable complexity, to
include in most complex versions, the coupled dynamics of
antigen-presenting cells, natural killer (NK) cells, T-helper cells,
plasma B cells, and cytotoxic T lymphocytes, based on previous
models [21,25]. Lastly, the intermediary state of exposed cells,
characterizing infected-non-infectious cells, was added in both
simple and complex versions of the model to obtain SEI-type
models [20].
Spatially-structured respiratory tract. The tracheo-bron-
chial tree is composed of the trachea and successive generations of
bifurcating bronchi and bronchioles of decreasing length and
diameter, through which air is transported. Terminal and
respiratory bronchioles feed into alveolar ducts and inter-
connected alveoli forming pulmonary acini, where vital gas
exchange takes place. The bifurcating structure of the respiratory
tract allows for a rapidly expanding epithelial surface area (and
thus cell pool) towards the deeper lungs [26] (Table 1). Different
cell types line different parts of the respiratory tract [26–28]. The
tracheal and bronchial epithelium contains predominantly ciliated
cells, as well as mucus-producing goblet cells. Together, these cells
form the muco-ciliary escalator, which traps and propels particles
towards the pharynx [29]. In contrast, the bronchiolar epithelium
contains predominantly non-ciliated cells. The alveolar epithelium
is composed of flat type I pneumocytes, forming the thin barrier
between air and blood, and more numerous cuboidal type II
pneumocytes, secreting surfactant and reabsorbing fluids [3].
Heterogeneities in the abundance, distribution and function of
respiratory epithelial cells have a major impact on different
properties of the respiratory tract (Table 1). First, because of the
muco-ciliary escalator, particles depositing in the trachea and
bronchi have a higher probability of being cleared towards the
pharyngeal area than those depositing in the bronchioles and
alveoli [29–33]. Second, because of the more delicate nature and
vital function of deeper airways and alveoli, damage caused to the
bronchiolar and alveolar epithelia has more severe consequences
than damage to the tracheal and bronchial epithelia [3]. Third,
different types of cellular receptors used by influenza virus are
expressed on the surface of the different respiratory epithelial cells.
Ciliated epithelial cells and type I pneumocytes predominantly
harbor sialic acids with a2,6 linkage to galactose, which are the
cellular receptors preferentially used by human influenza A
viruses. In contrast, non-ciliated epithelial cells and type II
pneumocytes predominantly harbor sialic acids with a2,3 linkage
to galactose, which are the receptors preferentially used by avian
influenza viruses [5–7,34]. The cellular tropism of avian influenza
viruses and the spatial distribution of their target cells, more
abundantly present in DRRT in humans, explain at least partly
their higher pathogenicity compared to that of human influenza
viruses [5–7].
Lastly, the dynamics and nature of host immune responses
markedly differ along the respiratory tract (Table 1). Following
infection, specific neutralizing immunoglobulins of type A and G
(IgA and IgG, respectively) are differently distributed along the
respiratory epithelium, limiting re-infection of underlying cells
[35–37]. IgA are actively secreted along the epithelium of the
airways, with higher concentrations in URRT. They are short-
lived and undetectable generally 1 to 3 months following infection.
In contrast, IgG passively diffuse from the serum and mostly line
the respiratory epithelium of DRRT. They are long-lived and can
be detected in circulation several years after infection. Although
cellular adaptive immune responses, including cytotoxic T-cell
responses, have not been quantified in similar detail in different
regions of the respiratory tract, they also appear stronger and
Figure 1. Conceptual overview of the framework. Within-host models of infection dynamics in a spatially-structured respiratory tract
composed of three linearly-connected compartments are used to estimate overall virus excretion (X) and pathogenicity (P). The parameters that differ
per respiratory compartment (i) are the initial number of susceptible cells (S0,i), the viral clearance rate (xi), and the distribution coefficients of
immunoglobulins of type A (IgA) and IgG (cai and cgi, respectively). The measures of virus excretion (X) and pathogenicity (P) in turn are used to
estimate population-level transmission rate (bh), mortality rate (ah), and recovery rate (ch), which define the virus reproductive number (R). See
Methods for more details.
doi:10.1371/journal.pone.0043115.g001
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longer-lived in DRRT [38,39]. As a result, protection against re-
infection with influenza virus typically lasts longer in DRRT than
in URRT, preventing severe disease (associated with DRRT
infection) but not necessarily infection (of URRT in particular).
The respiratory epithelium therefore is not a continuous and
homogeneous cellular layer available for influenza virus infection,
despite being a common assumption of most previously published
within-host models of influenza virus infection dynamics [20–
22,25,40–46]. Spatial heterogeneities associated with the structure
of the respiratory tract can have marked impact on viral excretion
and infection severity [44]. To account for these spatial
heterogeneities, we applied the mathematical models of within-
host infection dynamics to linearly-connected respiratory com-
partments delineating three different regions: trachea and bronchi
(compartment 1), bronchioles (compartment 2), and alveoli
(compartment 3), associated with one pulmonary lobe. These
three regions were chosen because they correspond to histolog-
ically distinct structures of the respiratory tract. We did not include
the naso-pharyngeal cavity because we aimed at determining
influenza virus optimal tropism in the respiratory tract located
distally from the pharynx (commonly referred to as the lower
respiratory tract). Because the gradients in cell numbers, clearance,
pathogenicity and antibody concentrations follow the same trends
when the naso-pharyngeal cavity is included [3,26,36,37], adding
this compartment to the model is unlikely to change the overall
patterns described below.
To account for the differences in abundance and distribution of
cells with sialic acids with a2,3 or a2,6 linkage to galactose, we
considered two populations of cells in each respiratory compart-
ment. Characteristics other than the linkage type of the sialic acids
(e.g., shape and length as well as glycan modification and
sialylation [47–49]) are undoubtedly important in defining the
suitability of these as receptors for influenza virus. However, the
distribution and abundance along the respiratory tract of the
diversity of sialic acids beyond the linkage type have not been
assessed in sufficient quantitative details for adequate modelling.
Therefore, we assumed that the non-ciliated respiratory epithelial
cells along the airways and type II pneumocytes in the alveoli
harboured a2,3 receptors (recognized by avian influenza viruses),
and that the ciliated respiratory epithelial cells along the airways
and type I pneumocytes in the alveoli harboured a2,6 receptors
(recognized by human influenza viruses), based on attachment
pattern studies [4–6]. This assumption may lead to an overesti-
mation of the number of susceptible cells available for infection;
however, it captured the relevant trends in the relative abundance
of susceptible cells available for avian or human influenza virus
infection, as seen in attachment pattern studies [4–6]. Namely, the
relative abundance of cells available for avian influenza virus
infection increased deeper down the respiratory tract, while that of
cells available for human influenza virus infection was larger in
URRT. The infectivity rate (b) was modulated by affinity
coefficients (a2,3 and a2,6) in the respective cell populations to
account for variable receptor binding affinity profiles. The general
format of the models based on two populations of susceptible cells
and applied to a respiratory compartment (i) was defined as
follows:
Cells with sialic acids with a2,3 linkage to galactose.
Susceptible cells
dS1i=dt~{a2,3bS1iVi{cS1iFi
Infected cells
dI1i=dt~a2,3bS1iVi{aI1i{etI1iTi
Cells refractory to infection
dR1i=dt~cS1iFi ð2Þ
Cells with sialic acids with a2,6 linkage to galactose.
Susceptible cells
dS2i=dt~{a2,6bS2iVi{cS2iFi
Infected cells
dI2i=dt~a2,6bS2iVi{aI2i{etI2iTi
Cells refractory to infection
dR2i=dt~cS2iFi ð3Þ
The dynamics of infection and host immune responses were
linearly connected between the three respiratory compartments, as
follows (for compartment i):
Table 1. Characteristics of the human respiratory tract.
Trachea and bronchi Bronchioles Alveoli Ref.
Epithelial surface area , handkerchief . half a tennis court [26]
Main cell types (type of sialic
acid-galactose linkage)
Ciliated epithelial cells (a2,6)
and goblet cells (a2,3)
Non-ciliated epithelial
cells (a2,3)
Type I pneumocytes (a2,6) and
type II pneumocytes (a2,3)
[4–7,26–28,34]
Particle clearance within
24 hours
High Intermediate Low [29–32]
Severity of damage
(resulting disease)
Mild (tracheo–bronchitis) Moderate (bronchiolitis) Severe (pneumonia) [3,67]
Concentration of IgA High Intermediate None [36,37]
Concentration of IgG Low Intermediate High [36,37]
IgA: immunoglobulins of type A; IgG: immunoglobulins of type G.
doi:10.1371/journal.pone.0043115.t001
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Total infected cells
Ii~I1izI2i
Free infective virus
dVi=dt~vp 1{pð ÞIizpqIi{1zp 1{qð ÞIiz1½ {
mvVi{eaAiVi{egGiVi{xiVi
Type I interferon
dFi=dt~
prf 1{pð ÞIizpqIi{1zp 1{qð ÞIiz1½ {mf Fi
Cytotoxic T cells
dTi=dt~prt 1{pð ÞIizpqIi{1zp 1{qð ÞIiz1½ Dtt{mtTi{etIiTi ð4Þ
Free infective virus present in one compartment (Vi) were
produced by infected cells from the same compartment (Ii) at a
probability 1-p; from the compartment located above (Ii21) at a
probability pq; and from the compartment located below (Ii+1) at a
probability p(1-q). Similarly, type I interferon present in one
compartment (Fi) was produced by infected cells from the same
compartment (Ii) at a probability 1-p; from the compartment
located above (Ii21) at a probability pq; and from the compart-
ment located below (Ii+1) at a probability p(1-q). Lastly, cytotoxic T
lymphocytes proliferating in one compartment (Ti) were stimulat-
ed by infected cells from the same compartment (Ii) at a probability
1-p; from the compartment located above (Ii21) at a probability
pq; and from the compartment located below (Ii+1) at a probability
p(1-q). The quantities pq and p(1-q) were set proportional to the
cross-sectional areas of the smallest bronchi and bronchioles, and
ranged from 1023.5 to 1021.8.
All parameters of the within-host models of infection dynamics
were identical in each respiratory compartment (i), except for the
initial number of susceptible cells (Si,0) (and their death rate if
included; see above), the rate of virus clearance (xi) and the
distribution coefficients of IgA and IgG (cai and cgi, respectively).
The number of cells susceptible to infection in each respiratory
compartment (S0,i) was estimated for the surface area of trachea
and bronchi, bronchioles and alveoli associated with one
pulmonary lobe, based on the Weibel model of the respiratory
tract and published estimates of the proportions of the various cell
types in different regions of the adult respiratory tract [26–28]. It
resulted in 107.7, 108.9 and 1010.2 epithelial cells with sialic acids
with a2,6 linkage to galactose; and 107.5, 109.5 and 1010.5
epithelial cells with sialic acids with a2,3 linkage to galactose in the
trachea and bronchi, bronchioles, and alveoli, respectively. The
virus clearance rate from each of the respiratory compartments (xi)
differed in accordance with data on the clearance rate of particles
depositing in different regions of the respiratory tract [29–32]. It
was estimated at 0.7 day21 in the tracheo-bronchial compartment,
0.5 day21 in the bronchiolar compartment and 0.05 day21 in the
alveolar compartment. Lastly, spatial heterogeneities in the
distribution of IgA and IgG along the respiratory tract were
introduced by adding distribution coefficients, cai and cgi,
respectively, that differed per compartment. The distribution
coefficients were estimated based on data obtained in mice [36,37],
because of the lack of data in humans (Table 2). We assumed that
IgA and IgG were produced centrally upon infection before being
redistributed in each compartment. This was done to mimic active
excretion of IgA and passive diffusion of IgG from serum.
IgA
dAi=dt~caipai
X
Vi
 
Dta{maAi{eaAiVi
IgG
dGi=dt~cgipgi
X
Vi
 
Dtg{mgGi{egGiVi ð5Þ
The relative distribution of cytotoxic T cells in different regions
of the respiratory tract is largely unknown therefore no spatial
heterogeneities in their dynamics were introduced. When we
retrospectively introduced higher production rates of cytotoxic T
cells deeper down the respiratory tract, it did not alter the overall
patterns described below (Fig. S3).
Fitting procedures. Although some parameters of the
within-host models of infection dynamics could be derived from
available data on human influenza virus infection, a number of
parameters required estimation (Table 2). This was done by fitting
the models by non-linear least squares to datasets of viral excretion
in nasal washes [50], type I interferon concentration in nasal
washes [51], IgA and IgG concentrations in serum [52] of human
volunteers infected with seasonal influenza virus and, due to lack
of human data, cytotoxic T lymphocyte (CD8+) counts in
broncho-alveolar lavages of mice infected with seasonal influenza
virus (mice being the most often used animal model of human
immune response dynamics) [53,54]. The sum of squared residuals
(SSR) between the experimental data and the models’ results in log
scale was minimized using the function optim in R [55]. Although
the datasets used for the fitting procedures referred to samples
collected from specific locations within the respiratory tract or
from serum, we assumed that these data were representative of the
dynamics of infection and immune responses in the respiratory
tract as a whole; hence the curves produced by the models in each
compartment were summed and fitted altogether to the data.
Similarly to previously published models, simple and more
complex versions of the within-host model of infection dynamics
quantitatively captured the central features of the dynamics of viral
infection and host immune responses (Fig. 2). However, we
emphasize that some care must be taken when interpreting the
individual parameter estimates because of possible redundancy
among the parameters of simple and a fortiori more complex versions
of the model. Nevertheless, uncertainty analyses on sets of estimated
parameters using latin hypercube sampling [56] revealed that fitted
estimates belonged to a robust parameter space that produced
dynamics consistent with the available data (Fig. S1).
Mathematical Model of Cross-scale Infection Dynamics
The within-host models of infection dynamics were subsequent-
ly nested into between-host models of the classic SIR (Susceptible-
Infected-Recovered) type in a homogeneous and well-mixed
human population:
Susceptible hosts
dSh=dt~{bhShIh
Tissue Tropism and Fitness of Influenza Virus
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Infected hosts
dIh=dt~bhShIh{ahIh{chIh
Recovered hosts
dRh=dt~chIh ð6Þ
Susceptible hosts Sh become infected at a transmission rate bh.
Infected hosts Ih die from infection at a mortality rate ah or
recover from infection at a recovery rate ch.
Quantitative assessment of viral excretion and
pathogenicity. The transmission rate (bh), mortality rate (ah)
and recovery rate (ch) of the population-level SIR model were
estimated based on quantitative assessment of viral excretion (X)
and pathogenicity (P) derived from the within-host models of
infection dynamics. Viral excretion (X) was approximated as the
total amount of cleared virus above a transmission threshold (T),
which was parameterized to obtain an infectious period (LX)
within the range of published measures of influenza infectious
period (3 to 5 days) [57]:
X~
X
i
ð
xiVi{Tð Þdt for xiVi§T ð7Þ
The use of a transmission threshold (T) allowed accounting for a
minimal infectious dose below which virus transmission to a new
individual was not successful.
We approximated pathogenicity (P) as the total number of
infected cells (I) in the simple versions of the model:
P~
X
i
ð
biSiVið Þdt ð8Þ
Because the lesions and clinical signs of influenza are a result of
the death of respiratory epithelial cells, influx of inflammatory
cells, and correlate with the levels of produced cytokines, we
approximated pathogenicity (P) as the sum of the total number of
infected cells, cytotoxic T lymphocytes and type I interferon in the
more complex versions of the model; these sums were calculated
over the duration of the infectious period (LX). X and P are
correlates rather than explicit measures of viral excretion and
pathogenicity, similarly to what can be measured empirically.
Estimation of SIR model transmission, mortality and
recovery rates. Linear and non-linear (logistic) functions were
explored to characterize the transmission and mortality rates (bh
and ah, respectively) as functions of viral excretion (X) and
pathogenicity (P). The transmission rate (bh) was set as a positive
function of viral excretion (X) and a negative function of
pathogenicity (P). Pathogenicity (P) was used to estimate the
transmission rate (bh) because lesions and clinical signs associated
with influenza may on the one hand impede viral transmission
(e.g., through damage to the muco-ciliary escalator, mechanical
obstruction of the airways or both) and on the other hand impair
infected individuals thereby reducing contacts between infected
and non-infected individuals. The maximum value of bh was fixed
so that R0 reached a maximum between 2.5 and 3.5, in
accordance with R0 estimates of pandemic influenza viruses in
the human population [58,59]. The mortality rate (ah) was set as a
Table 2. Range of parameter estimates of the within-host models of infection dynamics.
Parameter Value Ref.
b Infectivity rate{ (log) 210.0 to 26.0 explored
c Refractory state rate (log) 23 to 21.9 fitted
1/a Lifespan of infected cells 12 hours [80]
vp Virus production rate (log) 2 fixed
1/mv Lifespan of virus particles 12 hours [81]
x Viral clearance rate (day21) 0.7 (x1); 0.5 (x2); 0.05 (x3) [29–32]
prf Production rate of type I interferon (log) 21.9 to 20.9 fitted
prt Proliferation rate of cytotoxic T cells (log) 23.1 to 22.5 fitted
pra Production rate of IgA (log) 22.2 to 7.0 fitted/fixed
{
prg Production rate of IgG (log) 23.1 to 7.0 fitted/fixed
{
ca Distribution coefficient of IgA 0.7 (ca1); 0.3 (ca2); 0 (ca3) [37]
cg Distribution coefficient of IgG 0.01 (cg1); 0.3 (cg2); 0.7 (cg3) [37]
1/mf Lifespan of type I interferon 8 hours [82]
1/mt Lifespan of cytotoxic T cells 10 days [83]
1/ma Lifespan of IgA 5 days [84–86]
1/mg Lifespan of IgG 20 days [84–86]
et Killing rate of cytotoxic T cells (log) 23.3 to 22.0 fitted
ea Neutralization rate of IgA (log) 212.2 to 29.3 fitted
eg Neutralization rate of IgG (log) 210.6 to 29.1 fitted
{Rates are given per hour if not otherwise indicated.
{In more complex versions of the models, IgA and IgG production rates were fixed to the maximal value indicated, to reduce the number of redundant free parameters.
doi:10.1371/journal.pone.0043115.t002
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positive function of pathogenicity (P). The maximum value of ah
was fixed based on the case-fatality rate of highly pathogenic avian
influenza H5N1, estimated at 60% [60]. The recovery rate (ch)
was set as the reciprocal of the duration of the infectious period
(LX) when surviving infection:
ch~1=LXe
{ahLX ð9Þ
The actual relationships between viral excretion and pathoge-
nicity on the one hand, and transmission, mortality and recovery
rates of influenza on the other currently are poorly understood,
and remain to be empirically characterized. Therefore, the
framework described here is an exploration of the possible
reciprocal feedbacks between tissue tropism and reproductive
fitness, based on the general transmission-virulence trade-off
hypothesis, i.e., on the assumption that a certain level of
pathogenicity maximizes transmission [61]. As such, we assumed
transmissibility was possible, regardless of receptor binding affinity
profile, and sustained human-to-human transmission only oc-
curred when the virus basic reproductive number was above one
(R0.1; see below).
Calculation of influenza virus reproductive number. In
an immunologically naı¨ve population, the virus basic reproductive
number (R0) was calculated as:
R0~bh= ahzchð Þ ð10Þ
For R0.1, the effective reproductive number of the virus in a
population with pre-existing immunity (Re) was calculated one
year following virus circulation in an immunologically naı¨ve
population as:
Re~S
bh= ahzchð ÞzCbhp= ahpzchp
  ð11Þ
where S* is the proportion of individuals immunologically naı¨ve to
the virus and equals 1/R0; and C* is the proportion of individuals
with pre-existing immunity following infection the preceding year
and equals 1–1/R0. The subscripts h and hp define rates following
primary infection and re-infection with influenza virus, respec-
tively, as determined by the measures of viral excretion (X) and
pathogenicity (P) in a naı¨ve individual and in an individual with
pre-existing immunity, respectively. Contour plots of influenza
virus reproductive number were drawn using lattice functions in
R.
Results
Optimal Receptor Binding Affinity Profile
We determined the optimal receptor binding affinity profile of
influenza virus by varying the affinity coefficients a2,3 and a2,6 from
0 to 1. Influenza virus optimal receptor binding affinity profile was
defined as the combination of affinity coefficients a2,3 and a2,6 that
maximized the virus basic reproductive number (R0) in a human
population with no pre-existing immunity. The framework
predicted that a preferential affinity for sialic acids with a2,6
linkage to galactose (a2,6. a2,3) maximizes R0, and thus represents
the optimal strategy for the sustained circulation of influenza virus
in the human population (Fig. 3A). These results are in accordance
with preferred a2,6 receptor binding affinity of human influenza
viruses. However, there was a region in the parameter space of
preferential a2,3 receptor binding affinity (a2,3. a2,6) that resulted
in R0.1 (Fig. 3A).
In the above computation, virus pathogenicity (P) was calculated
as the unweighed sum of pathogenicity (Pi) in each respiratory
compartment (i):
P~
X
Pi ð12Þ
In other words, similar extent of damage caused to the
epithelium in each respiratory compartment contributed equally
to the overall pathogenicity of the infection (P). To further take
into account the more delicate nature and vital function of
bronchioles and alveoli, we alternatively calculated P as a weighed
sum of Pi where the contribution of pathogenicity in the
bronchiolar compartment (P2) and in the alveolar compartment
(P3) was 10
2 and 103 times as much, respectively, as that in the
tracheo-bronchial compartment (P1):
Figure 2. Within-host model dynamics. Output of within-host
models is represented by curves. Black line: mean values across models;
grey shaded area: standard deviation. Data points from empirical
studies are represented by symbols. A. Viral shedding; B. Type I
interferon; C. Cytotoxic T cells; D. Immunoglobulins of type A (IgA;
triangles) and IgG (crosses). HI: hemagglutination inhibition.
doi:10.1371/journal.pone.0043115.g002
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Figure 3. Optimal receptor binding affinity patterns. Contour plots of influenza virus basic reproductive number R0 (color scales) are drawn
when the affinity coefficients a2,3 (x axis) and a2,6 (y axis) are varied from 0 to 1. For all graphs, the initial number of susceptible cells differ per
respiratory compartment to reflect the heterogeneities in abundance and distribution of epithelial cells with sialic acids with a2,3 or a2,6 linkage to
galactose. The effect of heterogeneities in viral clearance rates (xi) and in the contribution of pathogenicity in each respiratory compartment (Pi) to
the overall virus pathogenicity (P) on the virus R0 is determined, when either non-linear or linear functions link within-host model output of viral
excretion (X) and pathogenicity (P) to between-host model parameters. For panels A to D, x1. x2. x3; for panels E and F, x1 = x2 = x3. For panels A,
C and E, P =g Pi; for panels B, D and F, P = P1+102 P2+103 P3. For panels A, B, E and F, non-linear functions link within-host model output to
between-host model parameters; for panels C and D, linear functions link within-host model output to between-host model parameters.
doi:10.1371/journal.pone.0043115.g003
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P~P1z10
2P2z10
3P3 ð13Þ
Under these conditions, preferential a2,6 receptor binding
affinity maximized R0, as previously. However, preferential a2,3
receptor binding affinity generally resulted in R0,1 (Fig. 3B). This
suggests that heterogeneities in the extent of damage associated
with the infection in different regions of the respiratory tract may
contribute to the limited ability of influenza virus with preferred
a2,3 receptor binding affinity (e.g., avian influenza viruses) to
efficiently circulate in the human population.
In the above computations, non-linear functions were used to
link within-host model output of viral excretion (X) and
pathogenicity (P) to between-host model transmission rate (bh),
mortality rate (ah), and recovery rate (ch). Similar optimal receptor
binding affinity patterns were obtained when using linear functions
(Fig. 3C and 3D). To determine whether these optimal patterns
were driven solely by the differences in the number of susceptible
cells in each respiratory compartment (S0,i), we set the virus
clearance rates (xi) or IgA and IgG distribution coefficients (cai and
cgi) to identical values in all three respiratory compartments, in
combination with equal or heterogeneous relative contributions of
pathogenicity in each compartment. Setting virus clearance rates
to identical values (x1 =x2 = x3) resulted in opposite patterns
depending on the relative contributions of pathogenicity in each
compartment. When the relative contributions were equal (Eq.
12), a preferential a2,3 receptor binding affinity maximized R0
(Fig. 3E); in contrast, heterogeneities (Eq. 13) resulted in optimal
a2,6 receptor binding affinity (Fig. 3F). On the other hand, setting
IgA and IgG distribution coefficients to identical values (ca1 = -
ca2 = ca3 and cg1 = cg2 = cg3) did not alter the optimal receptor
binding affinity patterns, regardless whether the relative contribu-
tions of pathogenicity in each compartment were equal or
heterogeneous (data not shown). Therefore, the models suggest
that spatial heterogeneities in virus clearance, virus pathogenicity
or both may drive influenza virus towards a preference for a2,6
receptors.
Optimal Infectivity Rates
Empirically, the tissue tropism of influenza viruses is not
exclusively determined by their receptor binding affinity for sialic
acids with a2,3 or a2,6 linkage to galactose. For example, sialic
acid shape and length, as well as glycan modifications such as
fucosylation, sulphation, and additional sialylation are known to
modulate influenza virus binding affinity [47–49]. Furthermore,
besides receptor binding affinity, variable replication efficiency can
characterize related virus variants and result in different infection
levels in different regions of the respiratory tract [62–64].
Accordingly, we explored the effect of variable infectivity for cells
in the different regions of the respiratory tract on the reproductive
fitness of human influenza virus (with affinity coefficients a2,3 = 0
and a2,6 = 1), by independently varying the infectivity rate (bi) in
each respiratory compartment (i) from 10210 to 1026 h21. Here,
the maximum value of the mortality rate (ah) was based on the
case-fatality rate of the 1918 pandemic influenza, estimated at 2%
[2]. We determined the optimal tissue tropism of human influenza
virus circulating in a completely naı¨ve population (e.g., during a
pandemic), as well as in a population with pre-existing immunity
(e.g., during the following season). Optimal tissue tropism or
optimal infectivity rates were defined as the combination of
infectivity rates (bi) that maximized the virus reproductive number
at the population level.
The optimal tissue tropism of human influenza virus in an
immunologically naı¨ve population was characterized by an
infectivity rate in the tracheo-bronchial compartment (b1) that
was approximately 100-fold greater than in the bronchiolar
compartment (b2; Fig. 4A); the infectivity rate in the alveolar
compartment (b3) that maximized R0 was consistently the lowest
in the explored range (1000-fold lower than b1). The optimal b2/
b1 ratio was maintained above 1 as long as the initial number of
susceptible cells in the bronchiolar compartment (Si,2) was greater
than that in the tracheo-bronchial compartment (Si,1; Fig. 5).
These trends were obtained whether the relative contributions of
pathogenicity in each compartment (Pi) to overall pathogenicity (P)
were equal or heterogeneous (Eq. 12 and 13, respectively). These
results suggest that the heterogeneities in the abundance of target
cells along the respiratory tract contribute to decreasing optimal
infectivity rates of human influenza virus deeper down the
respiratory tract.
The presence of pre-existing immunity changed the optimal
tissue tropism of human influenza virus: optimal infectivity rate in
the tracheo-bronchial compartment (b1) was higher, optimal
infectivity rate in the bronchiolar compartment (b2) was lower,
while optimal infectivity rate in the alveolar compartment (b3)
remained lowest within the explored range (Fig. 4B). As expected,
the presence of pre-existing immunity resulted in a decrease in the
reproductive number of human influenza virus. The maximal
values of Re did not exceed 1.7 and were in the upper range of
estimates of the reproductive number of seasonal influenza viruses
[65]. The lower reproductive number, together with the changes
in optimal tissue tropism, resulted in a decrease in both the
infection rate and case-fatality rate in the partially immune
population, compared to those in the immunologically-naı¨ve
population (Fig. 4C). The reduced case-fatality rate was caused in
part by reduced pathogenicity in the bronchiolar compartment
(P2) both in naı¨ve and immune individuals (Fig. 4D); this was
associated with the reduced optimal infectivity rate in the
bronchiolar compartment (b2). The models thus indicate that
influenza viruses circulating in partially-immune populations may
have increased tropism for URRT and be less pathogenic than
influenza viruses circulating in immunologically naı¨ve populations,
due to decreased tropism for DRRT.
Sensitivity to Model Structure and Parameters
Similar tropism patterns (Fig. S2 and S3) were produced by
both simple and more complex versions of the within-host model
of infection dynamics, combining either linear or non-linear
functions linking within-host model output of viral excretion (X)
and pathogenicity (P) to between-host model transmission rate
(bh), mortality rate (ah), and recovery rate (ch). Sensitivity analyses
to variations in the model parameters that were identical in all
three respiratory compartments were performed. Latin hypercube
sampling [56] was used to generate 100 sets of randomly sampled
non-fitted parameter values within 50%–200% of their initial
values, against which the estimated parameters were fitted by non-
linear least squares. Of these 100 sets of parameters, 10 were
randomly chosen to determine the tropism patterns of human
influenza virus in an immunologically naı¨ve and in a partially-
immune population. For all models, the optimal infectivity rate in
the tracheo-bronchial compartment (b1) was consistently higher
when the virus was circulating in a partially-immune population
than when it was circulating in a naı¨ve population; conversely, the
optimal infectivity rate in the bronchiolar compartment (b2) was
consistently higher when the virus was circulating in a naı¨ve
population (Fig. S2). Therefore, the observed differences between
the optimal tissue tropism of human influenza virus circulating in
Tissue Tropism and Fitness of Influenza Virus
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an immunological naı¨ve population and that of human influenza
virus circulating in a partially-immune population were not
sensitive to the overall model structure and parameters common
to all three respiratory compartments. We further evaluated the
impact of each of the within-host model parameters that differed
per respiratory compartment on these observed differences.
Setting either the initial number of susceptible cells, the virus
clearance rate, or IgA distribution coefficient in each compartment
to equal values (S0,1 = S0,2 = S0,3, x1 = x2 =x3, or ca1 = ca2 = ca3,
respectively) did not alter the observed differences in optimal tissue
tropism patterns in naı¨ve and partially-immune populations (data
not shown). In contrast, setting IgG production rate in each
compartment to equal values (cg1 = cg2 = cg3) abolished these
differences, and resulted in the same optimal infectivity rates in
each compartment, independently of pre-existing immunity levels.
This suggests that long-lived IgG present more abundantly in
DRRT than in URRT following infection may drive influenza
virus tissue tropism towards URRT in a human population with
pre-existing immunity.
In conclusion, the observed optimal tropism patterns obtained
in this study arose from the characteristic differences between the
three respiratory compartments, and were independent of the
structure or level of complexity of the within-host model of
infection in each of these compartments. First, the optimal
receptor binding affinity for sialic acids with a2,6 linkage to
galactose was associated with differences in virus clearance or virus
pathogenicity (or the interactions between both) in the three
respiratory compartments. Second, the optimal infectivity rates in
the three respiratory compartments, which exhibited a decreasing
trend towards DRRT, were associated with the expanding cell
pool deeper down the respiratory tract, in combination with lower
clearance rates. Lastly, the increased URRT tropism and
Figure 4. Optimal patterns of tissue tropism and associated morbidity and mortality burdens. Contour plots of influenza virus
reproductive number (color scales) in an immunologically naı¨ve population (R0; A) and in a partially-immune population (Re; B) are drawn when the
infectivity rates b2 (x axis) and b1 (y axis) are varied. In all cases, the infectivity rate b3 is kept constant and equals the lowest infectivity rate in the
explored range (10210 h21). Note that the optimal tissue tropism differs in an immunologically naı¨ve and in a partially-immune population. C. The
total number of cases per 10 000 individuals (light grey bars) and the number of fatal cases per 100 000 individuals (black bars) are represented for
the influenza virus with optimal tissue tropism in an immunologically naı¨ve population (year 0) and for the influenza virus with optimal tissue tropism
in a partially-immune population (year 1). Their respective case-fatality rate is indicated by a dark grey diamond. D. The percentage reduction in
pathogenicity in the bronchiolar compartment (P2) of the influenza virus with optimal tissue tropism in a partially-immune population is shown in a
naı¨ve individual and in an individual with pre-existing immunity in year 1 compared to that of the influenza virus with optimal tissue tropism in an
immunologically naı¨ve population (year 0).
doi:10.1371/journal.pone.0043115.g004
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decreased DRRT tropism of influenza virus circulating in a
population with pre-existing immunity were associated with spatial
heterogeneities in the distribution and concentration of IgG in the
three respiratory compartments.
Discussion
The use of cross-scale models for influenza virus infection that
link within-host dynamics in a spatially-structured respiratory tract
to between-host dynamics at the population level, provides
important insights into the possible selective pressures driving
tissue tropism in the respiratory tract. To the best of our
knowledge, these are the first such models developed at that
interface. These models suggest that heterogeneities in virus
clearance, virus pathogenicity, or the interactions between both,
drive the receptor binding affinity of influenza virus towards sialic
acids with a2,6 linkage to galactose. These models also indicate
that the expanding cell pool deeper down the respiratory tract may
lead to decreasing optimal infectivity rates towards DRRT, and
that pre-existing immunity may drive influenza virus tissue tropism
towards URRT.
The prediction of the cross-scale models that preferential a2,6
receptor binding affinity maximizes influenza virus reproductive
fitness in a human population corresponds with field data, which
show that both sporadic influenza pandemics and annual influenza
epidemics are caused by influenza viruses with preferential a2,6
receptor binding affinity [2,34,66]. In the models, these patterns
were driven by spatial heterogeneities in virus clearance or virus
pathogenicity (or both) along the respiratory tract. Although the
assumed heterogeneities in influenza virus clearance and patho-
genicity associated with the location of infection currently cannot
be quantified from empirical data, indications for these exist. The
clearance of particles towards the pharyngeal area relies mainly on
the muco-ciliary escalator, whereby mucus secreted by goblet cells
and submucosal glands traps organic and inorganic particles
before being propelled towards the pharynx by the movements of
the cilia [29]. Extensive experimental studies have been performed
on the clearance rates of magnetic or radio-labeled particles of
variable size depositing in different regions of the respiratory tract
of human volunteers (e.g., [29–32]). They revealed that the
proportion of particles that are rapidly cleared towards the
pharyngeal area decreases when they are deposited deeper down
the respiratory tract. In particular, fast-cleared particles are mainly
deposited along the larger airways. In contrast, the smaller airways
are characterized by a higher proportion of slow-cleared particles,
and most particles that deposit in the alveolar region are mainly
cleared slowly by alveolar macrophages [33]. It is likely that virus
particles produced in URRT are likewise being cleared towards
the pharyngeal area at a higher rate than those produced in
DRRT. As a consequence, the transmission of virus particles
originating from URRT may be favored over that of virus particles
originating from DRRT.
Spatial heterogeneities in pathogenicity associated with the
location of influenza virus infection are well documented [3].
Primary viral pneumonia can occur upon acute influenza virus
infection. It is a severe, if not fatal, respiratory disease resulting
from infection of epithelial cells in DRRT and associated host
immune responses. Because damage following DRRT infection
affects vital gas exchange, it can result in respiratory insufficiency
and death. In contrast, infection of URRT generally results in less
severe disease, such as rhinitis and tracheo-bronchitis, associated
with mild to moderate respiratory and general symptoms [3,67].
Spatial heterogeneities in pathogenicity can result either from the
higher number of infected cells in DRRT compared to that in
URRT, due to the larger initial cell pool; or from damage that has
relatively more severe consequences on the infected individual
when located in DRRT than in URRT (i.e., when roughly the
same number of cells are infected in both regions). We explored
both assumptions by setting the relative contributions of patho-
genicity in each respiratory compartment to either equal values or
to heterogeneous values increasing deeper down the respiratory
tract. Although the positive impact of coughing induced by URRT
infection on transmission was not explicitly taken into account,
heterogeneous contributions of pathogenicity increasing deeper
down the respiratory tract would include such assumption. While
the prediction of optimal receptor binding affinity for a2,6
receptors was maintained under both assumptions, the mainte-
nance of R0 below 1 for viruses with preferred a2,3 receptor
binding affinity was dependent on heterogeneous relative contri-
butions of damage in each respiratory compartment to the overall
pathogenicity of infection. Therefore, the increased pathogenicity
of infection located deeper down the respiratory tract may
contribute to the limited ability of influenza viruses with preferred
a2,3 receptor binding affinity (e.g., avian influenza viruses) to
efficiently circulate in the human population.
We further explored the optimal tissue tropism of human
influenza viruses (with strict a2,6 receptor binding affinity) when
circulating in a human population with or without pre-existing
immunity. By allowing variable infectivity rates in the three
respiratory compartments, the models predicted that progressive
reduction of the virus infectivity for epithelial cells towards DRRT
maximized influenza virus reproductive fitness. This pattern was
associated with the expanding cell pool deeper down the
respiratory tract, in association with decreasing clearance rates.
The relative infection levels of different regions of the respiratory
tract by influenza virus are not often reported in the literature.
Because of the multifocal nature of influenza virus infection, it can
be difficult empirically to quantitatively compare the proportion of
infected cells in different regions of the respiratory tract.
Nevertheless, the results of the models tend to be consistent with
empirical data. In particular, seminal work by Smith and Sweet
[63] clearly emphasized the heterogeneities in infection levels of
Figure 5. Relationship between optimal b2/b1 ratio and Si,2/Si,1
ratio in the absence of pre-existing immunity. The optimal
infectivity rate in the bronchiolar compartment (b2) is smaller than the
optimal infectivity rate in the tracheo-bronchial compartment (b1)
provided that the initial number of susceptible cells in the bronchiolar
compartment (Si,2) is larger than the initial number of susceptible cells
in the tracheo-bronchial compartment (Si,1).
doi:10.1371/journal.pone.0043115.g005
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various strains of influenza virus in URRT and DRRT of ferrets
(considered the most appropriate animal model for influenza
pathogenesis in humans [4–6]). Infection levels were typically
found to be higher in URRT than in DRRT, and infection of
alveolar epithelial cells was very rarely observed. In humans,
infection is also typically more marked in URRT than in DRRT,
and the absence of viral antigen in alveolar cells has also been
noticed following fatal infection with human influenza virus
[62,65,68,69]. Among the factors potentially explaining low levels
of influenza virus infection in the alveoli were lower viral
production rates by alveolar epithelial cells [63]. Although the
viral production rate was kept constant in the models, redundancy
does occur between viral production rate and infectivity rate. Thus
our findings are consistent with these observations, and may
provide an insight into the evolutionary mechanism behind the
lower infectivity of human influenza virus for DRRT.
Comparing the optimal tissue tropism of human influenza virus
in an immunologically naı¨ve population and in a population with
pre-existing immunity indicated that pre-existing immunity may
drive influenza virus tissue tropism even more towards URRT.
Associated with this, the case-fatality rate of human influenza virus
circulating in a partially immune population was reduced
compared to that of human influenza virus circulating in an
immunologically naı¨ve population, in part due to reduced
pathogenicity in DRRT. These results suggest that the tissue
tropism of influenza viruses may vary according to pre-existing
immunity levels in the human population. Low pre-existing
immunity levels may result in the circulation of viruses with
increased tropism for DRRT–and thus more pathogenic viruses–
compared to that of viruses circulating in a population with high
pre-existing immunity levels. This prediction is consistent with
more frequent observation of infected cells in DRRT of naı¨ve
ferrets inoculated with pandemic influenza viruses than in DRRT
of naı¨ve ferrets inoculated with seasonal influenza viruses [64,70].
Pre-existing immunity is also known to drive the evolution of
immune escape variants of seasonal influenza virus. In particular,
the surface proteins of seasonal influenza virus acquire amino-acid
substitutions through genetic mutations that make them less
recognizable by neutralizing antibodies targeting the surface
proteins of preceding strains. Some mutations have greater
antigenic effect than others [71], effectively reducing the level of
pre-existing immunity. As a result, immune escape variants with
large antigenic effect generally cause larger epidemics than do
preceding strains [72,73]. We may infer from our results that
immune escape variants may also have higher tropism for DRRT
than do preceding strains, and cause more severe disease. This
would be the case if their antigenicity was sufficiently distant from
previously-circulating strains that their circulation in the popula-
tion would be comparable to that of a virus circulating in a naı¨ve
population. Although variations in the tissue tropism of seasonal
influenza viruses in association with immune escape have not been
studied in detail, this prediction is in accordance with increased
DRRT tropism of a recent drift variant of seasonal influenza virus
H3N2 compared to that of strains circulating the preceding years
[62].
Because tissue tropism of influenza virus is among the
phenotypic traits at the interface of within- and between-host
infection dynamics, an individual host may not be considered as a
black box with a homogeneous and continuous cell monolayer
available for virus replication. Variations in tissue tropism may
result in variations in transmission and infectious period, which are
at the basis of the virus reproductive fitness, therefore creating
reciprocal feedbacks between within- and between-host infection
dynamics. The proposed cross-scale framework has shed light on
potential selective pressures driving influenza virus tissue tropism
along the respiratory tract, and has predicted patterns that are
consistent with empirical observations. However, as with most
models, there are a number of caveats. The framework builds on
assumptions regarding the relationships connecting within-host
infection dynamics and between-host transmission dynamics that
currently cannot be verified due to lack of data. In particular, the
models were built based on the general transmission-virulence
trade-off hypothesis [61]. We assumed that disease negatively
impacted virus transmission rate because it can impair infected
individuals and therefore reduce their contact with other
individuals; and also because respiratory lesions and associated
inflammation may impair the muco-ciliary escalator and mechan-
ically obstruct the airways, thus reducing excretion of virus
particles. We propose that these relationships may be inferred by
empirical testing of the predictions of this framework. Especially,
the relationships between viral pathogenicity, excretion, and
transmission in association with the location of infection along
the respiratory tract may be characterized in animal models
reproducing influenza virus pathogenesis as described in humans,
such as the ferret. As part of the between-host component of the
framework, only a well-mixed and homogeneous population of
human hosts was considered, and heterogeneities in transmission
rates and pre-existing immunity levels at the host population level
were ignored. For example, it is generally recognized that school-
age children play a major role in the transmission of influenza
virus [74–77]. Furthermore, pre-existing immunity levels are
strongly age-dependent [78,79]. This calls for further development
of the framework to include host population heterogeneities, in
association with empirical testing of its predictions. Because of
their very nature, even the simplest cross-scale models have a high
number of free parameters, and their complexity can rapidly
increase both at the within-host and between-host levels. However,
sensitivity analyses and model comparisons demonstrated that the
key fitness results arising from this study are robust. These key
fitness results represent hypotheses that are testable in an empirical
setting. As such, this model framework provides a template for the
mechanistic study of influenza virus cross-scale evolutionary and
epidemiological dynamics.
Supporting Information
Figure S1 Uncertainty analysis to simultaneous varia-
tions of within-host model parameter values. A. Peak
timing (days) and B. maxima (log) of viral excretion (1), type I
interferon production (2), cytotoxic T cell proliferation (3), and
immunoglobulins of type A (IgA; 4) and IgG (5) production, based
on 1000 sets of parameters generated by latin hypercube sampling,
ranging from 50% to 200% the fitted values. Thick line is the
median value, box lower and upper limits are the second and
fourth quartiles, and lower and upper whiskers are minimum and
maximum values.
(DOC)
Figure S2 Optimal tissue tropism of human influenza
viruses in populations with different levels of pre-
existing immunity based on simple and more complex
versions of the models (including models with param-
eter sets generated by latin hypercube sampling; see text
for details). The maximal reproductive number of human
influenza viruses is plotted for each value of their infectivity rate
for (A) tracheal and bronchial, (B) bronchiolar, and (C) alveolar
epithelial cells in a naı¨ve population (black) and in a partially
immune population (grey). Optimal tropisms are marked by a
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square. Infectivity rates are increasing from 1 to 5 as they differ per
model. Standard errors are represented.
(DOC)
Figure S3 Optimal patterns of tissue tropism based on
more complex versions of the model. Contour plots of
influenza virus reproductive number (color scales) in an immuno-
logically naı¨ve population (R0; left column) and in a partially-
immune population (Re; right column) are drawn when the
infectivity rates b2 (x axis) and b1 (y axis) are varied. In all cases,
the infectivity rate b3 is kept constant and equals the lowest
infectivity rate in the explored range (10210 h21). First row: the
within-host model of infection dynamics includes birth and death
processes of respiratory epithelial cells. Second row: the within-
host model of infection dynamics includes additional components
of the immune response, namely antigen-presenting cells, NK
cells, T-helper cells, plasma-B cells and CTL. CTL production
rate increases deeper down the respiratory tract. Third row: the
within-host model of infection dynamics includes an exposed state
characterizing infected-non-infectious epithelial cells (SEI-type
model). Infectivity rates increases from 1 to 5 as they differ per
model.
(DOC)
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